Skip to main content
TipRanks
Go Ultimate75% OFF

Benitec Biopharma (BNTC) Q3 2022 Earnings Report

319 Followers

BNTC Q3 2022 EPS Results

Actual EPS
-$6.80
Consensus EPS
-$7.48
Beat/Miss
Beat by +$0.68
One Year Ago EPS
-$14.00

BNTC Q3 2022 Revenue Results

Actual Revenue
$48.00K
Expected Revenue
$0
Beat/Miss
Beat by +$48.00K
YoY Revenue Growth
+4700.00%

Earnings Announcement Details

Quarter
Q3 2022
Date
05/16/2022
Time
Before Open
Conference Call
Monday, May 16, 2022
BNTC Upcoming Earnings

Benitec Biopharma's next earnings date is estimated for November 16, 2026, based on past reporting schedules.

Q3 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

BNTC Earnings History

BNTC earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 16, 20262027 (Q1)-0.28--0.22――
Sep 14, 20262026 (Q4)-0.26-0.26-0.4135.80% (+0.14)
May 14, 20262026 (Q3)-0.27-0.24-0.240.00% (+0.00)
Feb 12, 20262026 (Q2)-0.22-0.26-0.3321.21% (+0.07)
Nov 14, 20252026 (Q1)-0.45-0.22-0.4854.17% (+0.26)
Sep 22, 20252025 (Q4)-0.31-0.411.04-138.94% (-1.45)
May 14, 20252025 (Q3)-0.35-0.24-1.6485.37% (+1.40)
Feb 14, 20252025 (Q2)-0.78-0.33-2.6487.50% (+2.31)
Nov 14, 20242025 (Q1)-0.55-0.48-2.7682.61% (+2.28)
Sep 26, 20242024 (Q4)-0.491.04-0.0110500.00% (+1.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed